A randomized, double-blind comparison of the total dose of 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine required for effective local anesthesia during Mohs micrographic surgery for skin cancers

J Am Acad Dermatol. 2009 Mar;60(3):444-52. doi: 10.1016/j.jaad.2008.08.001.

Abstract

Objective: We sought to compare total lidocaine dose and patient comfort when using 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine during Mohs micrographic surgery.

Methods: In all, 149 patients were randomized to receive 1.0% lidocaine with 1:100,000 epinephrine or 0.5% lidocaine with 1:200,000 epinephrine during Mohs micrographic surgery. The total dose of lidocaine and measures of patient comfort were recorded.

Results: Compared with the 1.0% lidocaine group, there was a 52% reduction in lidocaine dose in the 0.5% group (mean difference, 147.85 mg; 95% confidence interval, 108.15-187.55; P < .001). Patient comfort was equivalent in both groups, as evidenced by the similar mean visual analog scale scores (P = .48) and mean volumes of rescue lidocaine administered (P = .18).

Limitations: No lidocaine blood levels were measured, and one Mohs surgeon performed all surgeries.

Conclusion: The dose of 0.5% lidocaine with 1:200,000 epinephrine provides pain control equivalent to 1.0% lidocaine with 1:100,000 epinephrine at approximately half the total lidocaine dose.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anesthesia, Local / methods*
  • Anesthetics, Local / administration & dosage*
  • Double-Blind Method
  • Epinephrine / administration & dosage*
  • Female
  • Humans
  • Lidocaine / administration & dosage*
  • Male
  • Middle Aged
  • Mohs Surgery*
  • Pain Measurement
  • Pain, Postoperative / diagnosis
  • Pain, Postoperative / prevention & control
  • Patient Satisfaction
  • Skin Neoplasms / surgery*
  • Vasoconstrictor Agents / administration & dosage*

Substances

  • Anesthetics, Local
  • Vasoconstrictor Agents
  • Lidocaine
  • Epinephrine